Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Pharma    save search

Zosano Pharma Announces Reverse Stock Split Effective Today
Published: 2022-04-11 (Crawled : 12:20) - ir.zosanopharma.com
ZSAN | $0.5576 7.23% -5.85% twitter stocktwits trandingview |
Health Technology
| | O: -8.49% H: 4.79% C: -10.03%

pharma today
FSD PHARMA ANNOUNCES CANCELLATION OF CERTAIN SHARES ISSUED TO FORMER CHIEF EXECUTIVE OFFICER DR. RAZA BOKHARI
Published: 2022-04-08 (Crawled : 07:00) - fsdpharma.com
HUGE | $0.6167 1.22% 29K twitter stocktwits trandingview |
Process Industries
| | O: 3.56% H: 0.06% C: -0.32%

pharma
Forward Pharma Reports Financial and Operating Results for the Year Ended December 31, 2021
Published: 2022-04-08 (Crawled : 22:00) - globenewswire.com
FWP | $1.95 7.74% 7.18% twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

pharma results
ESSA Pharma Announces the Presentation of Preclinical Data for its First Generation of Androgen Receptor N-Terminal Domain Degraders
Published: 2022-04-08 (Crawled : 19:00) - biospace.com/
EPIX | $6.67 -5.66% -6.0% 36K twitter stocktwits trandingview |
Health Technology
| | O: 1.77% H: 2.67% C: -1.34%

pharma preclinical presentation pre-clinical
MEI Pharma Announces Two Presentations at the American Association for Cancer Research Annual Meeting 2022
Published: 2022-04-08 (Crawled : 18:00) - biospace.com/
MEIP | $3.38 2.11% 2.07% 12K twitter stocktwits trandingview |
Health Technology
| | O: -0.82% H: 1.43% C: -0.88%

pharma research cancer
Vincerx Pharma Presents Preclinical and Preliminary Clinical Data on PTEFb/CDK9 Inhibitor VIP152 in Gynecologic Malignancies at the American Association for Cancer Research (AACR) Annual Meeting 2022
Published: 2022-04-08 (Crawled : 18:00) - globenewswire.com
VINC | $0.8967 -5.63% -5.97% 530K twitter stocktwits trandingview |
| | O: -0.52% H: 1.64% C: -5.26%

vip152 pharma research preclinical cancer pre-clinical
US Congress Introduces Bills to Strengthen Pharma Competition, Promote Innova...
Published: 2022-04-08 (Crawled : 17:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K twitter stocktwits trandingview |
Health Technology
| | O: 1.75% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M twitter stocktwits trandingview |
Health Technology
| | O: 2.1% H: 0.0% C: 0.0%

pharma
US Congress Proposes Bills to Strengthen Pharma Competition, Promote Innovation
Published: 2022-04-08 (Crawled : 15:20) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K twitter stocktwits trandingview |
Health Technology
| | O: 1.75% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M twitter stocktwits trandingview |
Health Technology
| | O: 2.1% H: 0.0% C: 0.0%

pharma
Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 20, 2022
Published: 2022-04-08 (Crawled : 07:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K twitter stocktwits trandingview |
Health Technology
| | O: 1.75% H: 0.0% C: 0.0%
NVO | $122.75 -1.43% 0.0% 2.8M twitter stocktwits trandingview |
Health Technology
| | O: -1.49% H: 1.22% C: 0.47%
SNY | News | $45.395 -1.55% -1.58% 4.4M twitter stocktwits trandingview |
Health Technology
| | O: 2.1% H: 0.0% C: 0.0%
IPHA | $2.4 -0.42% -0.42% 11K twitter stocktwits trandingview |
Health Technology
| | O: 3.55% H: 0.0% C: -1.87%

pharma
Correction: Zealand Pharma major shareholder announcement: Polar Capital LLP, April 7 2022
Published: 2022-04-07 (Crawled : 14:20) - globenewswire.com
ZEAL | $17.59 1.21% -4.21% twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

pharma
Thinking about buying stock in Vyne Therapeutics, Erytech Pharma, CDK Global, Euronav NV, or Aemetis?
Published: 2022-04-07 (Crawled : 14:00) - prnewswire.com
EURN | $16.37 -0.79% 0.0% 260K twitter stocktwits trandingview |
Transportation
| | O: 10.85% H: 0.56% C: -3.69%

pharma
FSD PHARMA ISSUES CORPORATE UPDATES
Published: 2022-04-07 (Crawled : 12:00) - fsdpharma.com
HUGE | $0.6167 1.22% 29K twitter stocktwits trandingview |
Process Industries
| | O: 0.0% H: 4.09% C: 1.59%

pharma
Zealand Pharma major shareholder announcement: The Capital Group Companies, April 7 2022
Published: 2022-04-07 (Crawled : 08:00) - globenewswire.com
ZEAL | $17.59 1.21% -4.21% twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

pharma group
Zealand Pharma's Annual General Meeting 2022
Published: 2022-04-06 (Crawled : 15:00) - globenewswire.com
ZEAL | $17.59 1.21% -4.21% twitter stocktwits trandingview |
Health Technology
| | O: -4.54% H: 3.6% C: 3.6%

pharma
FSD Pharma Issues Corporate Updates
Published: 2022-04-06 (Crawled : 13:00) - biospace.com/
HUGE | $0.6167 1.22% 29K twitter stocktwits trandingview |
Process Industries
| | O: -1.05% H: 4.54% C: -0.69%

pharma
Inozyme Pharma to Present at the 21st Annual Needham Virtual Healthcare Conference
Published: 2022-04-06 (Crawled : 13:00) - biospace.com/
INZY | $4.57 -1.72% -1.75% 560K twitter stocktwits trandingview |
Health Technology
| | O: -5.37% H: 2.66% C: 0.18%

pharma conference
Bruker Acquires Optimal Companies for Pharma PAT Software and Biopharma Manufacturing Automation Expertise and Technologies
Published: 2022-04-05 (Crawled : 12:20) - biospace.com/
BRKR | $78.56 -5.28% -5.58% 2.2M twitter stocktwits trandingview |
Health Technology
| | O: 0.08% H: 0.0% C: -2.4%

biopharma pharma companies software
Innate Pharma Files Its 2021 Universal Registration Document (Document d’enregistrement universel) and 2021 Annual Report on Form 20-F
Published: 2022-04-05 (Crawled : 07:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K twitter stocktwits trandingview |
Health Technology
| | O: -0.75% H: 0.0% C: 0.0%
NVO | $122.75 -1.43% 0.0% 2.8M twitter stocktwits trandingview |
Health Technology
| | O: 0.57% H: 1.02% C: 0.31%
SNY | News | $45.395 -1.55% -1.58% 4.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.64% H: 0.0% C: 0.0%
IPHA | $2.4 -0.42% -0.42% 11K twitter stocktwits trandingview |
Health Technology
| | O: 0.86% H: 0.0% C: -3.43%

pharma report
Inozyme Pharma Announces Positive Preliminary Data from Phase 1/2 Clinical Trial of INZ-701 in Patients with ENPP1 Deficiency
Published: 2022-04-04 (Crawled : 12:00) - globenewswire.com
INZY | $4.57 -1.72% -1.75% 560K twitter stocktwits trandingview |
Health Technology
| | O: 9.28% H: 8.01% C: 4.37%

inz-701 pharma trial positive phase 1
Press Release: Sanofi launches first-in-pharma Diversity, Equity & Inclusion Board
Published: 2022-04-04 (Crawled : 11:00) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.76% H: 0.0% C: 0.0%

sanofi pharma
Gainers vs Losers
64% 36%

Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M twitter stocktwits trandingview |
Finance

ZCMD | $2.86 108.76% 52.1% 2.3M twitter stocktwits trandingview |
Commercial Services

INVO | $1.555 104.6% 51.13% 5M twitter stocktwits trandingview |
Health Technology

ISPC | $0.437 105.16% 49.53% 37M twitter stocktwits trandingview |
Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M twitter stocktwits trandingview |

OST | $0.499 21.38% 45.26% 1.9M twitter stocktwits trandingview |

XPON | News | $3.1 60.62% 37.74% 17M twitter stocktwits trandingview |

TIRX | $0.7 44.39% 30.74% 58M twitter stocktwits trandingview |

BNTC | News | $6.92 44.17% 30.64% 3.5M twitter stocktwits trandingview |
Health Technology

GGE | $0.035 19.86% 29.3% 64M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.